Using a powerful gene-editing technique, scientists have rid human embryos of a mutation responsible for an inherited form of heart disease thats often deadly to healthy young athletes and adults in their prime.
The experiment marks the first time that scientists have altered the human genome to erase a disease-causing mutation not only from the DNA of the primary subject but from the genes of his or her progeny as well.
The controversial procedure, known as germ-line editing, was conducted at Oregon Health and Science University in Portland using human embryos expressly created for the purpose. It was reported Wednesday in the journal Nature.
Scientists ultimate goal is to fix gene mutations that lead to debilitating or fatal diseases, and to prevent the propagation of those mutations to future generations. Study leader Shoukhrat Mitalipov, a biologist at OHSU, said the new findings might correct genetic variants that can cause breast and ovarian cancer, cystic fibrosis and muscular dystrophy in those who inherit them.
But others fret that the technique may be used for less noble purposes, such as creating designer babies with desired traits like green eyes, an athletic build or an aptitude for mathematics.
In the United States, the Food and Drug Administration currently forbids any use of germ-line editing outside of a research setting.
But recent history has shown that people who want access to such techniques can find people willing to perform them in venues where theyre able to do so, said Jeffrey Kahn, who directs Johns Hopkins Universitys Berman Institute of Bioethics.
It will happen whether we discuss it or not, and we need to talk about these things before they happen, said Kahn. Thats now.
The new research comes less than six months after the National Academies of Science, Engineering and Medicine recommended that scientists limit their trials of human germ-line editing to diseases that could not be treated with reasonable alternatives at least for the time being.
In a bid to make the experiment relevant to the real-life problems faced by parents who carry disease-causing mutations, the researchers focused on a gene variant that causes inherited hypertrophic cardiomyopathy.
In this condition, a parent who carries one normal and one mutated copy of the MYBPC3 gene has a 50-50 chance of passing the faulty copy on to his or her offspring. If the child inherits the mutation, his or her heart muscle is likely to grow prematurely weak and stiff, causing heart failure and often early death.
In diseases in which one parent carries a gene like this, a couple will often seek the assistance of fertility doctors to minimize the risk of passing the mutation on to a child. A womans eggs and mans sperm meet in a lab using in vitro fertilization. Then specialists inspect the resulting embryos, cull the ones that have inherited an unwanted mutation, and transfer unaffected embryos into a womans uterus to be carried to term.
In the new research, researchers set out to test whether germ-line gene editing could make the process of choosing healthy embryos more effective and efficient by creating more of them.
It could. The targeted correction of a disease-causing gene carried by a single parent can potentially rescue a substantial portion of mutant human embryos, thus increasing the number of embryos available for transfer, the study authors reported.
The fix was made possible by a system known as CRISPR-Cas9, which has been sweeping through biology labs because it greatly simplifies the gene-editing process. It uses a small piece of RNA and an enzyme to snip out unwanted DNA and, if desired, replace it with something better.
If the process is found to be safe for use in fertility clinics, it could potentially decrease the number of cycles needed for people trying to have children free of genetic disease, said Dr. Paula Amato, a coauthor and professor of obstetrics and gynecology at Oregon Health and Science University.
The team encountered several scientific surprises along the way. Long-feared effects of germ-line editing, including collateral damage to off-target genetic sequences, scarcely materialized. And mosaicism, a phenomenon in which edited DNA appears in some but not all cells, was found to be minimal.
Mitalipov called these exciting and surprising moments. But he cautioned that there is room to improve the techniques for producing mutation-free embryos. Clinical trials would have to wait until the DNA editing showed a near-perfect level of efficiency and accuracy, he said, and could be limited by state and federal regulations.
There is still a long road ahead, said Mitalipov, who heads the Center for Embryonic Cell and Gene Therapy at OHSU.
Oregon Health & Science University
Human embryos developing into blastocysts after being injected with a gene-correcting enzyme and sperm carrying a mutation for a potentially fatal disease of the heart muscle.
Human embryos developing into blastocysts after being injected with a gene-correcting enzyme and sperm carrying a mutation for a potentially fatal disease of the heart muscle. (Oregon Health & Science University)
Oregon Health & Science University
Individual blastomeres within the early embryos two days after the co-injection. Each new cell in the developing embryos was uniformly free of the disease-causing mutation.
Individual blastomeres within the early embryos two days after the co-injection. Each new cell in the developing embryos was uniformly free of the disease-causing mutation. (Oregon Health & Science University)
Biologists, fertility doctors and ethicists have long anticipated that scientists would one day manipulate the DNA of human embryos. Now that the milestone has been reached, it drew a mix of praise and concern from experts in genetic medicine.
Dr. Richard O. Hynes, who co-chaired the National Academies report issued in February, called the new study very good science that advances the understanding of genetic repair on many fronts. Hynes, who was not involved with the research effort, said he was pleasantly surprised by the Oregon-based teams clever modifications and their outcomes.
Its likely to become feasible, technically not tomorrow, not next year, but in some foreseeable time. Less than a decade, Id say, said Hynes, a biologist and cancer researcher at MIT and the Howard Hughes Medical Institute.
UC Berkeley molecular and cell biologist Jennifer Doudna, one of pioneers of the CRISPR-Cas9 gene-editing system, said the new research highlights a prospective use of gene editing for one inherited disease and offers some insights into the process. But she questioned how broadly the experiments results would apply to other inherited diseases.
Doudna also said she does not believe using germ-line editing to improve efficiency at fertility clinics meets the criteria laid out by the National Academies of Sciences, which urged that the technology be explored only in cases in which its needed essentially as a last resort.
Already, 50% of embryos would be normal, she said. Why not just implant those?
Doudna said she feared that the new findings will encourage people to proceed down this road before the scientific and ethical implications of germ-line editing have been fully considered.
A large group of experts concluded that clinical use should not proceed until and unless theres broad societal consensus, and that just hasnt happened, she said. This study underscores the urgency of having those debates. Because its coming.
Kristyna Wentz-Graff/Oregon Health & Science University
Study leader Shoukhrat Mitalipov with coauthors Hong Ma, left, and Nuria Marti-Gutierrez.
Study leader Shoukhrat Mitalipov with coauthors Hong Ma, left, and Nuria Marti-Gutierrez. (Kristyna Wentz-Graff/Oregon Health & Science University)
The study authors a multinational team of geneticists, cardiologists, fertility experts and embryologists from OHSU, the Salk Institute in La Jolla, and labs in South Korea and China tested a number of innovations in an effort to improve the safety, efficiency and fidelity of gene editing. And most yielded promising results.
After retrieving eggs from 12 healthy female volunteers, the researchers simultaneously performed two steps that had never been combined in a lab: fertilizing the eggs with sperm and introducing the CRISPR-Cas9 repair machinery.
The resulting embryos took up the gene-editing program so efficiently and uniformly that, after five days of incubation, 72.4% of the 58 embryos tested were free of the MYBPC3 mutation. By comparison, when there was no attempt at gene editing, just 47.4% of embryos were free of the mutation responsible for the deadly heart condition.
The researchers believe their method prompted the embryos to rely on the healthy maternal copy of the gene as a model for fixing the MYBPC3 mutation, and not a repair template that used DNA from the sperm donors normal version of the gene. Only one of the 42 embryos used the introduced template for repair. The scientists contrasted this process to stem cells, which do use repair templates.
The embryos cells divided normally as they matured to the blastocyst stage, the point at which they would usually be ready for transfer to a womans uterus. After extensive testing, the embryos were used to make embryonic stem-cell lines, which are stored in liquid nitrogen and can be used in future research.
Researchers also noted that genetic mosaicism a concern raised by earlier experiments in gene-editing was virtually absent from 41 of the 42 embryos that were free of the disease-causing mutation.
MITs Hynes said such findings offer important insights into how human embryos grow, develop and respond to anomalies, and will help families facing infertility and inherited illnesses.
Human embryogenesis is clearly different from that of a mouse, which we know a lot about, Hynes said. That needs to be studied in human embryos, and theres no other way to do it.
At the same time, he downplayed fears that embryologists would soon tinker with such attributes as looks, personality traits and intelligence in human children.
Were not looking at designed babies around the corner not for a long time, he said.
MORE IN SCIENCE
The DNA of ancient Canaanites lives on in modern-day Lebanese, genetic analysis shows
You can predict how many blacks are killed by police by measuring the racism of whites, research finds
Is it Alzheimers or another dementia form? Why doctors need to distinguish and how they might do so
3:50 p.m.: This story has been updated with comments from Jeffrey Kahn of Johns Hopkins Universitys Berman Institute of Bioethics.
This story was originally published at 10 a.m.
- Stem Cell Therapy Market by Treatment,Application,End Users and Geography Forecast To 2026 - Markets Gazette 24 - November 11th, 2019
- Global Stem Cell Assay Market 2019 Size, Share, Growth, Trends, Type, Application, Analysis and Forecast by 2026 - Markets Gazette 24 - November 11th, 2019
- Oct4, Considered Vital for Creating iPSCs, Actually Isnt Needed - The Scientist - November 8th, 2019
- A winding romp through advances in cell biology pushes readers to ponder the boundaries of life - Science Magazine - October 31st, 2019
- Cell Banking Outsourcing Market to 2027 - Global Analysis and Forecasts By Product Type (Cord Cell Banking, Adult Stem Cell Banking, Embryonic Stem... - October 31st, 2019
- Cell Isolation Market ||Becton, Dickinson, and Company, Thermo Fisher Scientific, Inc., Merck KGaA - Industry News Info - October 31st, 2019
- Scientists Made Mice Live 12% Longer by Hacking Their Telomeres - Futurism - October 22nd, 2019
- Scientists extend mice lifespan 12% by tweaking telomeres - Big Think - October 22nd, 2019
- Merck KGaA opens Shanghai Innovation Center and invests $ 14 million in the China Seed Fund - asume tech - October 19th, 2019
- Health policy will be the focus of the HLTH - asume tech - October 19th, 2019
- Syros sees strategic shift after the failure of the previously promising cancer drug - asume tech - October 19th, 2019
- What Theranos Whistleblowers Learn About Ethics in Health Startups - asume tech - October 19th, 2019
- Assessments of Treatment Options for Age-related Macular Degeneration - DocWire News - October 15th, 2019
- Stem Cells Market Growth Rate, Production Volume and Future Opportunities From 2019-2024 - Exponent Online - October 15th, 2019
- Catholics more motivated to donate if ethical investing is assured - Crux: Covering all things Catholic - October 10th, 2019
- Greenwood to step down as CEO of BIO after 2020 election - FierceBiotech - October 10th, 2019
- Epigenetic initiation of the TH17 differentiation program is promoted by Cxxc finger protein 1 - Science Advances - October 10th, 2019
- Interview with Tamer Mohamed of Aspect Biosystems on Advancing Tissue Therapeutics - 3DPrint.com - October 10th, 2019
- Yale researchers develop way to help brain organoids thrive - Yale News - October 9th, 2019
- Catholics more motivated to donate if ethical investing is assured - The Catholic Spirit - October 9th, 2019
- Stem Cell Market: By Key Players, Market Competitive Landscape, Trends and Forecasts to 2024 - Joliet Observer - October 9th, 2019
- Stem Cell Therapy Market to Witness a Pronounce Growth During 2020 - Gem Newz - October 9th, 2019
- On creativity, plasticity and repentance - Arutz Sheva - October 5th, 2019
- What's in the cards for this year's Nobel Prizes? - STAT - October 2nd, 2019
- Moving beyond hype: Could one-two treatment restore damaged heart muscle? - University of Wisconsin-Madison - September 28th, 2019
- Conjugated polymers optically regulate the fate of endothelial colony-forming cells - Science Advances - September 28th, 2019
- God of miniscule things - Pune Mirror - September 27th, 2019
- New study shows insight into how cells maintain their identity - Drug Target Review - September 24th, 2019
- Human Embryonic Stem Cells Market: Expansion Strategies Set to Generate Substantial Revenue in the near Future - Rapid News Network - September 24th, 2019
- Global Stem Cells Market 2019 Strategic Assessment by Top Players CCBC, Vcanbio, Boyalife, Beikebiotech - News Coed - September 24th, 2019
- Study Gives Clues to the Origin of Huntington's Disease, and a New Way to Find Drugs - Nature World News - September 24th, 2019
- Global Stem Cells Market 2019 Business Statistics Focus Report Growth by Top Key Players CCBC, Vcanbio, Boyalife, Beikebiotec - The Industry News... - September 24th, 2019
- Orthopedic Biomaterials Product Market Set to Witness YoY Growth by 2018-2026 - NewsStoner - September 24th, 2019
- Global Fetal Bovine Serum Market : Industry Analysis and Forecast (2017-2026) - OnYourDesks - September 24th, 2019
- Stem Cell Therapy Market to Discern Steadfast Expansion During 2020 - Technology Trend - September 24th, 2019
- Embryonic Stem Cell - an overview | ScienceDirect Topics - May 22nd, 2019
- Embryonic Stem Cell Research and Vaccines using Fetal Tissue - May 6th, 2019
- Embryonic Stem Cells - Definitions, Use, and Research - April 28th, 2019
- Will Embryonic Stem Cells Ever Cure Anything? - MIT ... - April 28th, 2019
- Creating Embryonic Stem Cells Without Embryo Destruction - April 23rd, 2019
- What Are Stem Cells? - livescience.com - April 19th, 2019
- Embryonic Stem-Cell Research Reaches Moral, Medical Dead End - April 8th, 2019
- Embryonic Stem Cell: Definition, Uses and Collection ... - April 2nd, 2019
- Advantages of Embryonic Stem Cell Research | Sciencing - March 30th, 2019
- Practical Problems with Embryonic Stem Cells - usccb.org - March 20th, 2019
- Obama Ends Stem Cell Research Ban - CBS News - March 10th, 2019
- Types of Stem Cells A Closer Look at Stem Cells - January 26th, 2019
- Embryonic Stem Cell Research - rtlofneo.com - December 19th, 2018
- The Ethics Of Embryonic Stem Cell Research Viewpoint Essay - December 11th, 2018
- Embryonic Stem Cells and Artificial Stem Cells Are ... - December 5th, 2018
- Embryonic stem cells | Cells | MCAT | Khan Academy - November 25th, 2018
- Crucial Differences Between Non-Embryonic and Embryonic Stem ... - November 23rd, 2018
- 14 Key Pros and Cons of Embryonic Stem Cell Research ... - November 5th, 2018
- Human Embryonic Stem Cells in Development, Volume 129 ... - September 29th, 2018
- Reprogrammed stem cells identical to embryonic stem cells - September 29th, 2018
- Embryonic Stem Cell Protocols by Kursad Turksen | Waterstones - September 29th, 2018
- What Are Stem Cells? Research, Transplant, Therapy, Definition - July 17th, 2018
- Embryonic Stem Cell Research Pros and Cons | HRFnd - June 19th, 2018
- Stem Cell Research: Is It in Danger? - September 29th, 2017
- Truth About Embryonic Stem Cells | Stem Cell Orthopedic ... - September 29th, 2017
- Embryonic Stem Cell Research Still Hasn't Cured a Single ... - September 25th, 2017
- Doubts raised about CRISPR gene-editing study in human embryos - Nature.com - September 2nd, 2017
- Study shows human stem cells restore mobility in Parkinson's monkeys - Borneo Bulletin Online - September 2nd, 2017
- Sofa Vergara's ex might finally be out of luck in his battle for custody ... - Slate Magazine (blog) - September 1st, 2017
- Young cardiac cells rejuvenate heart in animal study - The San Diego Union-Tribune - August 29th, 2017
- embryonic stem cells : NPR - August 25th, 2017
- Mouse model of human immune system inadequate for stem cell studies - Stanford Medical Center Report - August 25th, 2017
- Injections of Vitamin C Could Help Fight Blood Cancer - Wall Street Pit - August 25th, 2017
- Letter: Response to 'Disappointed by Republicans' - The Herald-News - August 20th, 2017
- What are Embryonic Stem Cells? - amaskincare.com - August 19th, 2017
- Woman Will Use Stem Cells From Her Baby's Umbilical Cord To ... - LifeNews.com - August 19th, 2017
- Stem cells mimic sphere where embryos grow - Futurity: Research News - August 19th, 2017
- Vitamin C helps genes to kill off cells that would cause cancer - New Scientist - August 19th, 2017
- A way to stabilize haploidy in animal cells - Phys.Org - August 16th, 2017
- First implants derived from stem cells to 'cure' type 1 diabetes - New Scientist - August 12th, 2017
- Fast facts about cloning - WPSD Local 6: Your news, weather, and sports authority - WPSD Local 6 - August 12th, 2017
- Stem Cell Implant Is Being Trialled To Cure" Type 1 Diabetes - IFLScience - August 12th, 2017
- Lego-Like Brain Balls Could Build a Living Replica of Your Noggin - WIRED - August 12th, 2017
- Amniotic sac in a dish: Stem cells form structures that may aid of infertility research - Phys.Org - August 8th, 2017
- BioTech Marketing and market opportunity for Stem Cells - Checkbiotech.org (press release) - August 8th, 2017